Literature DB >> 17981033

Uncovering false positives on a virtual screening search for cruzain inhibitors.

Alberto Malvezzi1, Leandro de Rezende, Mario Augusto Izidoro, Maria Helena Sedenho Cezari, Luiz Juliano, Antonia do Amaral.   

Abstract

Some unexpected promiscuous inhibitors were observed in a virtual screening protocol applied to select cruzain inhibitors from the ZINC database. Physical-chemical and pharmacophore model filters were used to reduce the database size. The selected compounds were docked into the cruzain active site. Six hit compounds were tested as inhibitors. Although the compounds were designed to be nucleophilically attacked by the catalytic cysteine of cruzain, three of them showed typical promiscuous behavior, revealing that false positives are a prevalent concern in VS programs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17981033     DOI: 10.1016/j.bmcl.2007.10.068

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  The cysteine-rich protein thimet oligopeptidase as a model of the structural requirements for S-glutathiolation and oxidative oligomerization.

Authors:  Alberto Malvezzi; Patrícia M Higa; Antonia T-do Amaral; Gustavo M Silva; Fabio C Gozzo; Emer S Ferro; Leandro M Castro; Leandro de Rezende; Gisele Monteiro; Marilene Demasi
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

2.  Be Aware of Aggregators in the Search for Potential Human ecto-5'-Nucleotidase Inhibitors.

Authors:  Lucas G Viviani; Erika Piccirillo; Arquimedes Cheffer; Leandro de Rezende; Henning Ulrich; Ana Maria Carmona-Ribeiro; Antonia T-do Amaral
Journal:  Molecules       Date:  2018-07-27       Impact factor: 4.411

3.  Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents.

Authors:  Vicky Mody; Shashidharamurthy Taval; Joanna Ho; Savannah Wills; Ahmed Mawri; Latasha Lawson; Maximilian C C J C Ebert; Guillaume M Fortin; Srujana Rayalam
Journal:  Commun Biol       Date:  2021-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.